The Lifestyle Drugs Market Is Currently Worth A Phenomenal $23bn

Research and Markets has announced the addition of 'The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being' to their offering.

(PRWEB) October 22, 2004 -- Research and Markets (http://www.researchandmarkets.com/reports/c7847) has announced the addition of 'The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being' to their offering.

The lifestyle drugs market is currently worth a phenomenal $23bn. To boost its value pharmaceutical companies are actively searching for new lifestyle products and conditions. The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being, provides a timely market update, examining leading products and pipeline prospects in seven key lifestyle drug sectors, and is supported by forecasts to 2008. Today's R&D is influenced as much by commercial unmet needs as it is by clinical opportunities and chance. Pharmaceutical companies must react quickly to these needs if they are to reap greater financial returns. This report can help you to assess the premium associated with different lifestyle drug markets and identify the potential for higher volume sales. Armed with this information your company can formulate winning lifestyle drug development and marketing strategies, and secure a strong competitive position within this market.

Report Contents:

Chapter 1 The new premium pharmaceutical environment

Chapter 2 Depression

Chapter 3 Oral contraception

Chapter 4 Sexual dysfunction

Chapter 5 Smoking cessation

Chapter 6 Obesity

Chapter 7 Alopecia

Chapter 8 Skin aging

For more information visit http://www.researchandmarkets.com/reports/c7847

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###